InceptionR’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
+1,748
New +$648K 0.17% 232
2025
Q3
Sell
-1,195
Closed -$465K 748
2025
Q2
$465K Buy
+1,195
New +$481K 0.11% 335
2025
Q1
Sell
-3,885
Closed -$1.43M 626
2024
Q4
$1.43M Buy
3,885
+2,562
+194% +$1.07M 0.32% 81
2024
Q3
$688K Buy
+1,323
New +$707K 0.17% 239
2024
Q2
Sell
-3,323
Closed -$1.72M 662
2024
Q1
$1.72M Buy
3,323
+1,421
+75% +$707K 0.44% 24
2023
Q4
$897K Buy
+1,902
New +$879K 0.64% 1
2023
Q3
Sell
-979
Closed -$435K 446
2023
Q2
$435K Sell
979
-151
-13% -$69.7K 0.23% 174
2023
Q1
$520K Buy
1,130
+573
+103% +$273K 0.17% 236
2022
Q4
$286K Buy
+557
New +$283K 0.15% 289

Other funds holding ELV

InceptionR's ELV Position: Q2 2026 in Review

InceptionR opened a new position in Elevance Health (ELV) in Q2 2026: 1,748 shares worth $676K. The stake represents 0.17% of the portfolio and ranks #232 among its holdings. This is a return to the name: InceptionR previously reported a position in ELV as recently as Q2 2025.

InceptionR first reported a position in ELV in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.72M in Q1 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • InceptionR held 1,748 shares of Elevance Health worth $676K as of Q2 2026.
  • Elevance Health was a new InceptionR position in Q2 2026.
  • Elevance Health made up 0.17% of InceptionR's portfolio in Q2 2026, its #232 holding.
  • InceptionR first reported a position in Elevance Health in Q4 2022 and has held it in 9 quarters since.
  • InceptionR's Elevance Health position peaked at $1.72M in Q1 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.